Cargando…
Separating the microbiome from the hyperbolome
Microbiome-based therapies are moving quickly towards the clinic, with successes including fecal microbial transplants for recurring Clostridium difficile, hints of new antibiotics to come, and possible new microbial biomarkers for common complex diseases. Can the microbiome live up to its hype?
Autor principal: | Shanahan, Fergus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337103/ https://www.ncbi.nlm.nih.gov/pubmed/25709718 http://dx.doi.org/10.1186/s13073-015-0143-5 |
Ejemplares similares
-
Reincarnations of the phase separation problem
por: Dong, Ruo-Yu, et al.
Publicado: (2021) -
Targeting the microbiome: from probiotics to fecal microbiota transplantation
por: Khoruts, Alexander
Publicado: (2018) -
Microbiome ethics, guiding principles for microbiome research, use and knowledge management
por: Lange, Lene, et al.
Publicado: (2022) -
Microbes and microbiomes in 2020 and beyond
por: Natarajan, Aravind, et al.
Publicado: (2020) -
The nasopharyngeal microbiome and LRTIs in infants
por: Rogers, Geraint B
Publicado: (2019)